• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Call To Action: Survey for 9th LuCE Report

Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]

Association of Patients with Respiratory Failure and Lung Transplantation joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as the Bulgarian Association of Patients with Respiratory […]

LuCE seeks to fill key roles

Join our team at Lung Cancer Europe (LuCE) and become part of a dedicated group of individuals who are driven […]

ALK Positive Europe joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as Alk Positive Europe joins the LuCE family. […]

Alk+ France cancer poumon joins Lung Cancer Europe

We are very happy that Alk Ros1 France Cancer Poumon has become a member of Lung Cancer Europe (LuCE).Alk+ France […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]